Cited by 82Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

Quantitative neurohistological features of frontotemporal degeneration

Open access
Arnold, Steven E., Han, Li-Ying, Clark, Christopher M., Grossman, Murray, Trojanowski, John Q.·2000·Neurobiology of Aging

Abstract

Frontotemporal degeneration (FTD) is a neurodegenerative condition that has been principally associated with frontal lobe dementia. In this study, we compared neuropathological abnormalities in frontal, hippocampal, and calcarine cortices from patients assigned a diagnosis of FTD, normal elderly and Alzheimer's disease (AD). Densities of Nissl-stained neurons and lesions which were immunolabeled for tau, beta-amyloid (Abeta), alpha- and beta-synuclein, ubiquitin, glial fibrillary acidic protein (GFAP) and CD68 antigen were determined using computer-assisted, non-biased quantitative microscopy. We found that FTD frontal and hippocampal regions exhibited marked neuron loss, abundant ubiquitin-immunoreactive (ir) dystrophic neurites, GFAP-ir astrocytes, and CD68-ir microglia, while calcarine cortex was spared. No alpha- or beta-synuclein-ir lesions were observed, and neither the density of tau-ir neurofibrillary tangles nor that of Abeta-ir plaques in FTD exceeded normal controls. In addition, there were no neuropathological differences between FTD subjects who presented clinically with a frontal lobe dementia versus an AD-like dementia. These findings indicate that FTD is a category of neurodegnerative dementias with varying clinical presentations that is characterized by the progressive degeneration of select populations of cortical neurons. The molecular neurodegenerative mechanisms that lead to FTD remain to be elucidated.

Integrity signals

Registry

Crossref · 10.1016/s0197-4580(00)00173-1

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In vivo PET and immunohistochemistry studies found increased microglial activation in the frontal and temporal cortices of patients with FTD.

    “In vivo PET studies320,321 and immunohistochemistry studies322–324 have found increased microglial activation in the frontal and temporal cortices of patients with FTD.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Arnold, S. E., Han, L.-Y., Clark, C. M., Grossman, M., & Trojanowski, J. Q.
Affiliations
University of Pennsylvania (US)
Corresponding author
Arnold, Steven E.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2000-11
Volume
21
Issue
6
Pages
913-919
ISSN
0197-4580 (ISSN-L)
OpenAlex
W1986349982
Cited by
82
References
31
Citations by year
2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 4
FWCI
3.04
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Aging (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (AG09215, P30AG010124, P01AG009215, AG-10124)
  • National Institute of Mental Health (MH-55199, R29MH055199)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
frontotemporal lobar degeneration, frontal lobe dementia, Alzheimer's disease, neuronal loss, astrocytes, microglia, neurofibrillary tangles, amyloid plaques, synuclein, calcarine cortex, neurodegeneration
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Astrocytes, Autopsy, Brain, Dementia, Female, Glial Fibrillary Acidic Protein, Humans, Male, Neurons, Organ Size, Ubiquitins, Neurites, Microglia, Neurodegenerative Diseases, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review